Collection of Biological Specimen and Data from patients with malignancy treated at John Theurer Cancer Center and Hackensack University Medical Center Read more
A Phase I/II Open Label Study to Evaluate the Safety, Cellular Kinetics, and Efficacy of AZD0754, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against STEAP2, in Adult Participants with Metastatic Prostate Cancer Read more
Phase I/II, Two-Part, Multicenter First-in-Human Study of DS-7300a in Subjects With Advanced Solid Malignant Tumors Read more
Gene Alteration Differences in Patients with Solid Cancer between Hispanic and Non-Hispanic Population Read more
A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors Read more
Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors with KRAS G12D Mutation. Read more
A Phase 1 Study of the Safety and Tolerability of IPH4502 in Subjects with Selected Advanced or Metastatic Solid Tumors Read more
A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4175408, an Antibody Drug Conjugate Targeting Protein Tyrosine Kinase 7-Expressing Tumor Cells, in Participants with Selected Advanced Solid Tumors Read more
A Phase 1, Open-Label, Dose Escalation and Expansion, Multicenter Study of Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects with Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma Read more
